Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults-Reference-Cited by-同舟云学术

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

Published:2020-08-04 Issue:2 Volume:17 Page:554-559
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Scaggs Huang Felicia¹,Bernstein David I.¹,Slobod Karen S.²,Portner Allen²,Takimoto Toru²,Russell Charles J.²³,Meagher Michael⁴,Jones Bart G.²,Sealy Robert E.²,Coleclough Christopher²,Branum Kristen²,Dickey Michelle¹,Buschle Kristen¹,McNeal Monica¹,Makowski Mat⁵,Nakamura Aya⁵,Hurwitz Julia L.²³

Affiliation:

1. Department of Pediatrics, University of Cincinnati College of Medicine, Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

2. Department of Infectious Diseases, Jude Children’s Research Hospital, Memphis, TN, USA

3. Department of Microbiology, Immunology and Biochemistry, University of Tennessee Health Science Center, Memphis, TN, USA

4. Children’s GMP LLC, Memphis, TN, USA

5. The Emmes Company, Rockville, MD, USA

Funder

American Lebanese Syrian Associated Charities

National Cancer Institute

National Institute of Allergy and Infectious Diseases

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy